Searched for
EISAI PHARMA
Roche's Alzheimer's drug fails to meet goal in long awaited trialRoche's Alzheimer's drug candidate could not be shown to markedly slow dementia progression in two drug trials, leaving rivals Biogen and E...- Heavyweights pull Nikkei lower, Topix gains on drugmakers' boostNikkei inched down 0.2 per cent to close at 28,963.56, while the Topix edged up 0.1 per cent at 1,962.65.
- Glenmark Pharma launches anti-epileptic drug, Rufinamide, in the USThe newly launched drug is a therapeutic equivalent of Banzel tablets, 200 mg and 400 mg of Eisai, Inc. Banzel tablets are used in combinat...
- YSR government's concern for ‘brand Vizag’ increase over rising industrial accidentsWhile the government is directing the authorities towards a comprehensive study to evolve a robust regulatory mechanism to avert accidents,...
- Illegal cancer drugs from Bangladesh flood local marketIllegal import of drugs from Bangladesh and other neighbouring countries have further added to the woes of pharmaceutical companies. Expert...
- Emcure to launch generic breast cancer medicineEribulin, sold by Japanese drug maker Eisai under brand name Halaven, is used to treat HER 2 negative patients. It costs Rs 5,000 per vial.
- Nikkei closes flat even as chip makers make a buzzChip equipment makers jumped, tracking a rise in US tech shares overnight.
- Japanese companies make cautious return to Indian pharma marketOther drug companies whose acquisition went southwards included Mitsui & Co, which acquired a significant stake in Arch Pharma.
- Pharma companies like Medtronic and Dr Reddy’s innovate with financing schemes for cheaper treatmentCompanies are experimenting with offers such as installments, free diagnostic tests, discounts and even tailor-made insurance schemes to ma...
- Lupin gets FDA nod for generic Aricept tabletsLupin said it has received final approval from the US drug regulator to market generic Aricept tablets used for treatment of dementia.
- Helsinn Healthcare in settlement agreement with Dr Reddy'sAccording to a statement by the drug maker, Aloxi is currently distributed by Helsinn Healthcare's marketing partner, Eisai Inc in the USA.
- Glenmark gets tentative USFDA nod to sell RufinamideGlenmark Pharmaceuticals today said it has been granted tentative approval by the US health regulator to sell Rufinamide.
- Japan asks Prime Minister Narendra Modi to clear policy hurdles for companiesToyota, on the other hand, has been facing labour unrest that hit production at its plant in Bidadi, about 30 km from Bangalore.
- Japan's Eisai to launch breast cancer drug in IndiaJapan's Eisai Pharma is slated to launch in India its novel anti-cancer drug Eribulin, sold under the brand name of Halaven.
- Sun Pharma receives USFDA nod for generic Alzheimer's drugSun Pharmaceutical Industries said it has received a tentative approval from US health regulator to market generic donepezil hydrochloride ...
- Astellas aims to emerge top player in transplantationJapan’s second-largest pharma company, the $10-billion Astellas Pharma, intends to emerge as a niche player in India.
- Telengana unrest takes a heavy toll on pharma industry in APPharma companies in Andhra Pradesh say they are losing heavily due to the Telengana unrest in the State.
- Ranbaxy to shift admin to MumbaiRanbaxy Laboratories, India’s largest pharma company by sales, is looking to shift its marketing and administrative teams from its Gurgaon ...
- Tokyo's Eisai to invest Rs 500 cr in Vizag SEZTokyo-based pharma major Eisai has zoomed on India to set up a new Rs 500 crore manufacturing and R&D centre.
- DRL expects verdict in Aciphex case by May 15As the patent clash between Dr Reddy's Labs (DRL) and Japanese pharma firm Eisai for the control over $1.3-billion anti-ulcer drug Aciphex ...
Load More
